Aptar Pharma says new eDevices will speed up regulatory approval

from Outsourcing-Pharma Podcast · host William Reed Ltd

Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.

Episode metadata supplied by the publisher feed · Published Feb 21, 2012

Embed this episode

Attribution link and audio player

NOW PLAYING

Aptar Pharma says new eDevices will speed up regulatory approval

0:00 5:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Outsourcing-Pharma Podcast?

This episode is 5 minutes long.

When was this Outsourcing-Pharma Podcast episode published?

This episode was published on February 21, 2012.

Can I download this Outsourcing-Pharma Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!